382 related articles for article (PubMed ID: 33390561)
1. Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2.
ElBini Dhouib I
Drug Discov Ther; 2021 Jan; 14(6):262-272. PubMed ID: 33390561
[TBL] [Abstract][Full Text] [Related]
2. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain.
Dey J; Alam MT; Chandra S; Gupta J; Ray U; Srivastava AK; Tripathi PP
J Med Virol; 2021 Mar; 93(3):1296-1303. PubMed ID: 32964419
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.
Singal CMS; Jaiswal P; Seth P
ACS Chem Neurosci; 2020 Jul; 11(13):1887-1899. PubMed ID: 32491829
[TBL] [Abstract][Full Text] [Related]
4. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
[TBL] [Abstract][Full Text] [Related]
5. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
[TBL] [Abstract][Full Text] [Related]
6. Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and α-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders.
Follmer C
ACS Chem Neurosci; 2020 Dec; 11(24):4012-4016. PubMed ID: 33244974
[TBL] [Abstract][Full Text] [Related]
7. Role of SARS-CoV-2 neurotropism and neuroinvasion in COVID-19 patients disease severity.
Grijalva-Otero I
Gac Med Mex; 2020; 156(4):339-343. PubMed ID: 32831327
[TBL] [Abstract][Full Text] [Related]
8. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
9. Emerging neurotropic features of SARS-CoV-2.
Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
[TBL] [Abstract][Full Text] [Related]
10. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
Alam SB; Willows S; Kulka M; Sandhu JK
Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
[TBL] [Abstract][Full Text] [Related]
11. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
Galanopoulos M; Doukatas A; Gazouli M
World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
[TBL] [Abstract][Full Text] [Related]
12. Does COVID-19 contribute to development of neurological disease?
Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and neurodegenerative diseases.
Fu YW; Xu HS; Liu SJ
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
[TBL] [Abstract][Full Text] [Related]
14. Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses.
Barrantes FJ
ACS Chem Neurosci; 2020 Sep; 11(18):2793-2803. PubMed ID: 32845609
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
Liang F; Wang Y
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835030
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases.
Mahalaxmi I; Kaavya J; Mohana Devi S; Balachandar V
J Cell Physiol; 2021 Feb; 236(2):763-770. PubMed ID: 32697344
[TBL] [Abstract][Full Text] [Related]
17. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses.
Hu J; Jolkkonen J; Zhao C
Neurosci Biobehav Rev; 2020 Dec; 119():184-193. PubMed ID: 33091416
[TBL] [Abstract][Full Text] [Related]
18. Dialogue between Neuroinflammation and Neurodegenerative Diseases in COVID-19.
Chowdhury B; Sharma A; Satarker S; Mudgal J; Nampoothiri M
J Environ Pathol Toxicol Oncol; 2021; 40(3):37-49. PubMed ID: 34587403
[TBL] [Abstract][Full Text] [Related]
19. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.
Wei C; Wan L; Yan Q; Wang X; Zhang J; Yang X; Zhang Y; Fan C; Li D; Deng Y; Sun J; Gong J; Yang X; Wang Y; Wang X; Li J; Yang H; Li H; Zhang Z; Wang R; Du P; Zong Y; Yin F; Zhang W; Wang N; Peng Y; Lin H; Feng J; Qin C; Chen W; Gao Q; Zhang R; Cao Y; Zhong H
Nat Metab; 2020 Dec; 2(12):1391-1400. PubMed ID: 33244168
[TBL] [Abstract][Full Text] [Related]
20. Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection.
Jagst M; Pottkämper L; Gömer A; Pitarokoili K; Steinmann E
Curr Opin Microbiol; 2024 Jun; 79():102474. PubMed ID: 38615394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
